Analytical Data
-
Gene name
BT_1636
- Application
-
Alternative Names
Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50); Hydrolase
-
Species
Others
-
Source
E. coli
-
Tag
His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8A789
-
Expression Region
Q23-K509
-
Protein Length
Full Length of Mature Protein
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BT_1636 is a protein that has garnered significant interest in the field of biotechnology and molecular biology due to its potential applications in therapeutic and industrial processes. This protein, derived from bacterial origins, plays a crucial role in various biological functions, including enzymatic reactions and metabolic pathways. The research surrounding BT_1636 focuses on its structural characteristics, functional mechanisms, and the possibilities of recombinant DNA technology for producing this protein in larger quantities. By understanding BT_1636’s interactions at the molecular level, scientists aim to harness its properties for use in drug development, enzyme replacement therapies, and biocatalysis. The ongoing studies also explore the protein’s stability and efficacy under different conditions, which are essential for its practical applications. Additionally, BT_1636 and its homologs can provide insights into evolutionary biology and the adaptation of organisms to specific environments, thereby enriching our understanding of biodiversity and protein evolution. Overall, the study of BT_1636 represents a promising avenue for innovation in protein engineering and biotechnology, paving the way for advancements in both health and industry.
